Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Forster

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
The Journal of Clinical Investigation|November 7, 2023
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammationMagnus T Dillon, Jeane Guevara, Kabir Mohammed, et al.
Clinical and Translational Medicine|March 12, 2025
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expressionJacklyn Liu, Helen Bewicke-Copley, Shruti Patel, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
Cancer Discovery|April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET RearrangementsSeshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Journal of Neurological Surgery. Part B, Skull Base|July 5, 2023
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging SystemMatt Lechner, Yoko Takahashi, Mario Turri-Zanoni, et al.
Nature Communications|January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapyMatt Lechner, Volker H Schartinger, Christopher D Steele, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
The Journal of Clinical Investigation|November 7, 2023
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammationMagnus T Dillon, Jeane Guevara, Kabir Mohammed, et al.
Clinical and Translational Medicine|March 12, 2025
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expressionJacklyn Liu, Helen Bewicke-Copley, Shruti Patel, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
Cancer Discovery|April 9, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET RearrangementsSeshiru Nakazawa, Federica Pecci, Igor Odintsov, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Journal of Neurological Surgery. Part B, Skull Base|July 5, 2023
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging SystemMatt Lechner, Yoko Takahashi, Mario Turri-Zanoni, et al.
Nature Communications|January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapyMatt Lechner, Volker H Schartinger, Christopher D Steele, et al.
Pageof 16